Pasar al contenido principal

PAPEL DEL LOS CANALOSOMAS KV1.5 Y KV4.3 EN LA FIBRILACION AURICULAR. BUSQUEDA DE NUEVAS DIANAS TERAPEUTICAS Y HERRAMIENTAS MOLECULARES

PID2022-137214OB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multiple pathways for lanthanide sensitization in self-assembled aqueous complexes

  • Navarro, Amparo
  • Ruiz-Arias, Alvaro
  • Fueyo-González, Francisco
  • Izquierdo-García, Carolina
  • Peñaa-Ruiz, Tomás
  • Gutiérrez-Rodríguez, Marta
  • Herranz, Rosario
  • Cuerva, Juan M.
  • Gonzáez-Vera, Juan A.
  • Orte, Angel
Lanthanide photoluminescence (PL) emission has attracted much attention for technological and bioimaging applications because of its particularly interesting features, such as narrow emission bands and very long PL lifetimes. However, this emission process necessitates a preceding step of energy transfer from suitable antennas. While biocompatible applications require luminophores that are stable in aqueous media, most lanthanide-based emitters are quenched by water molecules. Previously, we described a small luminophore, 8-methoxy-2-oxo-1,2,4,5-tetrahydrocyclopenta[de]quinoline-3-phosphonic acid (PAnt), which is capable of dynamically coordinating with Tb(III) and Eu(III), and its exchangeable behavior improved their performance in PL lifetime imaging microscopy (PLIM) compared with conventional lanthanide cryptate imaging agents. Herein, we report an in-depth photophysical and time-dependent density functional theory (TD–DFT) computational study that reveals different sensitization mechanisms for Eu(III) and Tb(III) in stable complexes formed in water. Understanding this unique behavior in aqueous media enables the exploration of different applications in bioimaging or novel emitting materials., This work was supported by grants PID2020-114256RB-I00 and PID2022-137214OB-C22 funded by Agencia Estatal de Investigacion (Spain) AEI/10.13039/501100011033; grants P21_00212, A-FQM-386- UGR20 and 2021/00627/001-FEDER_UJA_2020 funded by FEDER/ Junta de Andalucía-Consejería de Universidad, Investigaci´on e Innovaci´on (Andalucía regional government, Spain); the diaRNAgnosis project funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 101007934, CSIC (Spain) grant 202180E073, and PAIDI- FQM-337, Universidad de Jaén (Spain). Funding for open access charge: Universidad de Granada / CBUA. A.R.-A. thanks the Ministerio de Educación y Formación Profesional (Spain) for the FPU Ph.D. scholar- ship. The authors also acknowledge the Centro de Servicios de Informática y Redes de Comunicaciones (CSIRC) (Universidad de Granada, Spain) for providing the computing time and the Centro de Intrumentación Científica (CIC) (Universidad de Granada, Spain) for support with measurements at 77 K. The authors thank Prof. Juan M. Herrera for providing Gd(III) salts., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome

  • Cruz, F. M.
  • Macías, Á.
  • Moreno-Manuel, A. I.
  • Gutiérrez, L. K.
  • Vera-Pedrosa, M. L.
  • Sánchez Pérez, P.
  • Ruiz Robles, J. M.
  • Bermúdez-Jiménez, F. J.
  • Díaz-Agustín, Aitor
  • Martínez De Benito, F.
  • Arias-Santiago, S
  • Braza-Boils, A.
  • Martín-Martínez, Mercedes
  • Gutiérrez-Rodríguez, Marta
  • Bernal, J. A.
  • Zorio, E.
  • Jiménez-Jaimez, J.
  • Jalife, J.
BACKGROUND: Andersen-Tawil syndrome type 1 is a rare heritable disease caused by mutations in the gene coding the strong inwardly rectifying K channel Kir2.1. The extracellular Cys (cysteine)-to-Cysdisulfide bond in the channel structure is crucial for proper folding but has not been associated with correct channel function at the membrane. We evaluated whether a human mutation at the Cys-to-Cysdisulfide bridge leads to Kir2.1 channel dysfunction and arrhythmias by reorganizing the overall Kir2.1 channel structure and destabilizing its open state. METHODS: We identified a Kir2.1 loss-of-function mutation (c.366 A>T; p.Cys122Tyr) in an ATS1 family. To investigate its pathophysiological implications, we generated an AAV9-mediated cardiac-specific mouse model expressing the Kir2.1 variant. We employed a multidisciplinary approach, integrating patch clamping and intracardiac stimulation, molecular biology techniques, molecular dynamics, and bioluminescence resonance energy transfer experiments. RESULTS: Kir2.1 mice recapitulated the ECG features of ATS1 independently of sex, including corrected QT prolongation, conduction defects, and increased arrhythmia susceptibility. Isolated Kir2.1 cardiomyocytes showed significantly reduced inwardly rectifier K+ (I) and inward Na+ (I) current densities independently of normal trafficking. Molecular dynamics predicted that the C122Y mutation provoked a conformational change over the 2000-ns simulation, characterized by a greater loss of hydrogen bonds between Kir2.1 and phosphatidylinositol 4,5-bisphosphate than wild type (WT). Therefore, the phosphatidylinositol 4,5-bisphosphate-binding pocket was destabilized, resulting in a lower conductance state compared with WT. Accordingly, on inside-out patch clamping, the C122Y mutation significantly blunted Kir2.1 sensitivity to increasing phosphatidylinositol 4,5-bisphosphate concentrations. In addition, the Kir2.1 mutation resulted in channelosome degradation, demonstrating temporal instability of both Kir2.1 and Na1.5 proteins. CONCLUSIONS: The extracellular Cys-to-Cysdisulfide bond in the tridimensional Kir2.1 channel structure is essential for the channel function. We demonstrate that breaking disulfide bonds in the extracellular domain disrupts phosphatidylinositol 4,5-bisphosphate-dependent regulation, leading to channel dysfunction and defects in Kir2.1 energetic stability. The mutation also alters functional expression of the Na1.5 channel and ultimately leads to conduction disturbances and life-threatening arrhythmia characteristic of Andersen-Tawil syndrome type 1., This work was supported by the National heart, Lung and Blood Institute under National Institutes of Health (NIH) grant R01HL163943; the La Caixa Banking Foundation project code HR18-00304 (grant LCF/PR/HR19/52160013); grants PI-FIS-2020, PI20/01220, PI-FIS-2023, and PI23/01039 from the Instituto de Salud Carlos III and cofunded by the Fondo Europeo de Desarrollo Regional (FEDER) and the European Union, respectively; grants PID2020-116935RB-I00 and BFU2016-75144-R funded by MICIU/AEI/10.13039/501100011033; the Fundación La Marató de TV3 (736/C/2020) amb el suport de la Fundació La Marató de TV3; the CIBER (Centro de Investigación Biomédica en Red) de Enfermedades Cardiovasculares (grant CB16/11/00458); the European Union’s Horizon 2020 grant agreement GA-965286; and the Program S2022/BMD7229-CM ARCADIA-CM funded by the Comunidad de Madrid to J. Jalife; grant PID2021-126423OB-C22 (to M. Martín-Martínez) funded by MICIU/AEI/10.13039/501100011033; and European Regional Development Fund (ERDF) grant PID2022-137214OB-C22 (to M. Gutierrez-Rodríguez) funded by MICIU/AEI/10.13039/501100011033. The imaging studies were performed in the TRIMA@CNIC (Infraestructura de Imagen Traslacional Avanzada del CNIC) node of the ICTS ReDIB (Infraestructuras Científicas y Técnicas Singulares: Red Distribuida de Imagen Biomédica) grant ICTS-2018-04-CNIC-16 funded by MICIU/AEI/10.13039/501100011033 and ERDF, and project EQC2018-005070-P funded by MICIU/AEI/10.13039/501100011033 and FEDER. A.I. Moreno-Manuel holds an formación profesional universitaria (FPU) contract (FPU20/01569) from the Ministerio de Universidades. J.M. Ruiz Robles holds an FPU contract (FPU22/03253) from the Ministerio de Universidades. L.K. Gutiérrez holds an FPI contract (PRE2018-083530) from the Ministerio de Economía y Competitividad de España cofunded by the Fondo Social Europeo, attached to project SEV-2015-0505-18-2. I. Martínez-Carrascoso holds a PFIS (Contratos predoctorales de formación en investigación en salud) contract (FI21/00243) funded by Instituto de Salud Carlos III and the Fondo Social Europeo Plus cofunded by the European Union. M.L. Vera-Pedrosa held contract PEJD-2019-PRE/BMD-15982 funded by the Consejería de Educación e Investigación de la Comunidad de Madrid y Fondo Social Europeo.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microwave-assisted synthesis of new triangulenium dyes for lifetime imaging microscopy (FLIM)

  • Viedma-Barba, Carmen
  • Ortega-Naranjo, Esther M
  • Movilla, Federico
  • Reinoso, Antonio
  • Andrades-Amate, Marta
  • Peñalver, Pablo
  • Morales, Juan Carlos
  • González-Vera, Juan A
  • Gutiérrez-Rodríguez, Marta
  • Orte, Angel
This paper is dedicated to Dr. Rosario Herranz, whose leadership and mentorship have been a source of inspiration., We introduce a novel microwave-assisted method for the rapid and efficient synthesis of triangulenium dyes, enabling the creation of a broader range of these fluorophores, which are characterized by very long fluorescence lifetimes. We prepared different azadioxatriangulenium (ADOTA) and diazaoxatriangulenium (DAOTA) derivatives and thoroughly characterized their photophysical properties. We investigated their solvatochromic properties and the effects of the solvent, aided by computational chemistry results. The new ADOTA and DAOTA dyes were applied in multiple in cellulo microscopy modalities, including confocal, fluorescence lifetime imaging microscopy (FLIM), and super-resolution imaging. ADOTA derivatives predominantly accumulated in mitochondria, while DAOTAs showed pronounced nuclear staining and participation in endocytic pathways. Notably, these dyes enable clear discrimination of subcellular compartments via lifetime contrast in FLIM: mitochondria, where ADOTAs undergo electron transfer-driven quenching and display short lifetimes; nuclei and DNA, where lifetimes remain long; and endocytic vesicles, where partial dye aggregation leads to lifetime reduction., This work has been funded by grants PID2023-148243OB-I00 and PID2022-137214OB-C22 funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and “ERDF A way of making Europe”, EU; grant PID2020-114256RB-I00 funded by AEI/https://doi.org/10.13039/501100011033; CSIC grant 202180E073; C. Viedma-Barba holds a FPI Predoctoral contracts subsidized by Spanish Minister of Science and Innovation (PRE2020-093542) granted by MCIN/AEI/https://doi.org/10.13039/501100011033 and “ESF Investing in your future”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels

  • Cruz, Alicia de la
  • Ronchi, Carlotta
  • Bartolucci, Chiara
  • Socuéllamos, Paula G.
  • Benito-Bueno, Ángela de
  • Severi, Stefano
  • Zaza, Antonio
  • Valenzuela, Carmen
The resolution of inflammation is modulated by specialized pro-resolving lipid mediators (SPMs), which can be modified in some cardiovascular diseases. Among these SPMs, RvD1 and LXA4 prevent atrial fibrillation (AF) remodeling and cardiac hypertrophy, respectively in animal models. However, little is known about their electrophysiological effects on cardiac voltage-gated (VG) ion channels. We used the patch-clamp technique in heterologous systems and cardiomyocytes to assess the acute effects of RvD1, and LXA4, on VG potassium currents. In silico simulations were used to predict the effect of current modulation on the atrial and ventricular action potentials (AP). RvD1 (5 nM) reduced IKs (channel KV7.1/KCNE1) in COS-7 cells and guinea-pig cardiomyocytes by 50.3 ± 7.3 % and 29.9 ± 5.4 % at + 40 mV, respectively, without modifying its voltage dependence. RvD1 was more potent than LXA4. In heterologous systems, RvD1 was also tested on IKur (channel KV1.5), Ito (channel KV4.3/KChIP2), IKr (channel KV11.1), and IK1 (channel Kir2.1) with the largest inhibitory effect on IKs and IKr. In in silico simulations RvD1 prolonged repolarization significantly in both atrial and ventricular myocytes. All these results provide a comprehensive evaluation of RvD1 and LXA4 on cardiac human potassium channels, at pathophysiologically relevant concentrations, being RvD1 more potent than LXA4. The predicted effects on the AP suggest that, along with their antiinflammatory action, RvD1 may reverse AF-induced electrical remodeling in the atria by their modulation of K+ currents. The same action might instead contribute to ventricular functional remodeling; however, direct evidence for this is missing., This publication is the results of the: Grants PID2019–104366RB-C21 (to C.V.), PID2022–137214OB-C21 (to C.V.); funded by MCIN/AEI/10.13039/501100011033; Grant CB/11/00222 funded by Instituto de Salud Carlos III CIBERCV (to C.V.); Grants BES-2017–080184 (to A.d.B.-B.); Grant FPU17/02731 (to P.G.S.) funded by Ministerio de Ciencia e Innovación. NextGenerationEU through the Italian Ministry of University (C.B. and S.S) and Research under PNRR - M4C2-I1.3 Project PR 00000019 “HEAL ITALIA” (to S.S). CUP J33C22002920006 (C.B. and S.S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of a new selective ligand for targeting neuronal KV4.3/KChIP3 over cardiac KV4.3/KChIP2 channels

  • Socuellamos, Paula G.
  • Viedma-Barba, Carmen
  • de Benito-Bueno, Angela
  • Bonache de Marcos, María Ángeles
  • Ropero, Maria
  • Diez, Sara
  • Elizalde, Pablo
  • Marín-Olivero, Irene
  • Redondo-Moya, Maria
  • Naranjo, Jose Ramon
  • Gonzalez-Vera, Juan A.
  • Orte, Angel
  • Perez-Lara, Angel
  • Martín-Martínez, Mercedes
  • Valenzuela, Carmen
  • Gutiérrez-Rodríguez, Marta
The present study aimed to discover novel KChIP ligands as pharmacological tools for modulating the KV4.3/KChIP channels. A multidisciplinary approach, combining medicinal chemistry and electrophysiology studies, led to the successfully identification of a novel KV4.3/KChIP modulator (IQM-22110). Its design was guided by the previous knowledge of the (phenylacetamido)benzoic acid moiety as suitable scaffold, along with virtual screening of a focused chemical library that suggested improved KChIP3 binding upon incorporation of an additional aromatic ring. IQM-22110 was selected for synthesis and identified as a potent KChIP3 ligand. Its electrophysiological effects on KV4.3/KChIP3 currents indicate that IQM-22110 binds to a high affinity site in KV4.3/KChIP3 channels that it is not present in KV4.3/KChIP2 or KV4.3. To the best of our knowledge, here we describe the first KChIP3 ligand that selectively modulates KV4.3/KChIP3 versus KV4.3/KChIP2 and KV4.3 channels at nanomolar concentration. Since KChIP2 is predominantly expressed in cardiac tissue, this selectivity may enable the development of KV4.3/KChIP3-targeted therapeutics with reduced risk of cardiac side effects. Computational and site-directed mutagenesis studies allowed the identification of IQM-22110's binding site on KChIP3. Knowledge gained from structural and functional studies with this novel KChIP3 ligand could establish the basis for drug discovery programs fostering treatments for diseases in which KV4.3/KChIPs channels are involved., This work has been funded by grants: PID2022-137214OB-C21 (to CV) and PID2022-137214OB-C22 (to MG-R) funded by MCIN/AEI/h ttps://doi.org/10.13039/501100011033 and by “ERDF A way of mak ing Europe”; PID2023-148243OB-I00 AEI/https://doi.org/10.13039/ 501100011033 (to AO); Grant CB/11/00222 funded by Instituto de Salud Carlos III CIBERCV (to C.V.); CSIC grants 202580E109 (to MMM and MG-R) and 2023AEP049 (to CV); P. G. Socuéllamos was funded by FPU17/02731 granted by Spanish Minister of Science and Innovation. C. Viedma-Barba holds a FPI Predoctoral contracts subsidized by Spanish Minister of Science and Innovation (PRE2020-093542) granted by MCIN/AEI/https://doi.org/10.13039/501100011033 and “ESF Invest ing in your future”. A. de Benito-Bueno holds a FPI grant BES- 2017–080184. M. Redondo holds a FPI Contract subsidized by Spanish Minister of Science and Innovation (PREP2022-000706). A.P.-L. ac knowledges funding by a Ramon y Cajal grant (RYC2018-023837-I) and Max Planck Society through the funding of a Max Planck Partner Group on “Regulation of the SNARE zippering by complexins and synapto tagmins” at the University of Granada. We thank Centro de Supercomputaciónn de Galicia (CESGA) and Centro Técnico de Informática, CTI-CSIC for computer time at FinisTerrae III and DRAGO, respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lgi3-4 proteins modulate the KV1.5 channelosome and are potential therapeutic targets for atrial fibrillation

  • Socuéllamos, Paula G.
  • Macías, Álvaro
  • Benito-Bueno, Ángela de
  • Cruz, Francisco M.
  • Redondo-Moya, María
  • Coronado, María José
  • Ramil, Elvira
  • Rosado, Silvia
  • Rios-Rosado, Elsa Carolina
  • Valencia-Avezuela, María
  • Andrés-Delgado, Laura
  • Blázquez, José Antonio
  • Forteza-Gil, Alberto
  • Gutiérrez-Rodríguez, Marta
  • Jalife, José
  • Valenzuela, Carmen
We investigated the role of Lgi3-4 proteins in cardiac electrophysiology, with a specific focus on IKur, and their potential contribution to the pathophysiology of atrial fibrillation (AF)., Supported by Grants PID2019-104366RB-C21 (to C.V.), PID2019-104366RB-C22 (to M.G-R.), PID2022-137214OB-C21 (to C.V.); PID2022-137214OB-C22 (to M.G-R.) funded by MCIN/ AEI/10.13039/501100011033; Grant CB/11/00222 funded by Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (to C.V.); Grant S2022/BMD-7223 by Comunidad Autónoma de Madrid (CAM) (to C.V.); Grant FPU17/ 02731 (to P.G.S.); Grant BES-2017-080184 (to A.d.B.-B.); funded by Ministerio de Ciencia e Innovación. Supported also by National Heart, Lung and Blood Institute, NIH, grant number R01HL163943; La Caixa Banking Foundation project code HR18-00304 (LCF/PR/HR19/52160013); grants PI-FIS-2020 # PI20/01220 and PI-FIS-2023 # PI23/01039 from Instituto de Salud Carlos III (ISCIII) and co-funded by Fondo Europeo de Desarrollo Regional (FEDER), and by The European Union, respectively; grant PID2020-116935RB-I00 and BFU2016-75144-R funded by MCIN/AEI/10.13039/501100011033; Fundación La Marató de TV3 (736/C/2020) ‘amb el suport de la Fundació La Marató de TV3’; CIBERCV (CB16/11/00458; CB/11/00222 to CV); European Union’s Horizon 2020 grant agreement GA-965286; and Program S2022/BMD7229-CM ARCADIA-CM funded by Comunidad de Madrid (to JJ)., Peer reviewed